In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Derek Hennecke, biotech and CDMO Entrepreneur and Board Member.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Derek, covering:
The behind-the-scenes story of acquiring, growing and selling Xcelience to Capsugel
Why Derek loves a carve-out with a clear differentiating capability and bags of growth potential
How he thinks about investments in both a VC and PE capacity, and how this has evolved
Why Derek is not seeing a slowdown across his portfolio companies…but why there could be a lag

Derek is a biotech entrepreneur and Chairman of various boards, including Microsize and Particle Dynamics. With over 30 years of experience in the CDMO industry and a 2022 Master’s degree from Harvard in the Inceptor Bio lab, he has developed a deep understanding of pharmaceutical development and manufacturing, and as a Partner at Kineticos Ventures, he invests in biotech companies that are pushing the boundaries of what’s possible in oncology through technologies like gene editing, mRNA, and CAR-T.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.